| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Part 1: PD Registries in Asia |
Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
Correspondence to: Ikuto Masakane, 1-6-17 Honcho, Yamagata 990-0043
Japan.
masakane{at}yabuki.yamagata.yamagata.jp
By 31 December 2006, more than 260 000 patients were on dialysis therapy in
Japan, and 9243 of them (3.6%) were on peritoneal dialysis (PD). The mean age
of PD patients was 5 years less than that of all patients with chronic kidney
disease, and the prevalence of diabetes among them was 9.4% lower. Among the
PD patients, 18.0% were being treated with a combination of PD and
hemodialysis, and 33.4% were being treated with automated PD. A peritoneal
equilibration test (PET) had been performed in 22.0% of the patients, who were
then classified into the four PET categories. Of the tested patients, 10.3%
were placed in the low (L) category; 38.3% in the low-average (LA) category;
38.4%, in the high-average (HA) category; and 13.0%, in the high (H) category.
Icodextrin was used by 27.3% of patients classified L, 30.5% of those
classified LA, 47.1% of those classified HA, and 55.1% of those classified H.
The annual death rate was 6.1%, which was lower than the rate for HD (9.7%);
and the annual withdrawal rate was 19.8%. Infectious complications were the
main cause for lowered rates of patient and technique survival. Use of PD for
older and diabetic patients and of combination therapy with hemodialysis are
key perspectives in the most recent report on PD in Japan.
KEY WORDS: Japanese Society for Dialysis Therapy; patient registration; peritoneal dialysis regimen; peritoneal equilibration test; icodextrin; combination therapy with hemodialysis; patient survival; technique survival.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
 |
